A multicentre randomised phase II trial of gemcitabine alone vs gemcitabine and S-1 combination therapy in advanced pancreatic cancer: GEMSAP study

被引：0
|
作者：
Y Nakai
H Isayama
T Sasaki
N Sasahira
T Tsujino
N Toda
H Kogure
S Matsubara
Y Ito
O Togawa
T Arizumi
K Hirano
M Tada
M Omata
K Koike
机构：
[1] Graduate School of Medicine,Department of Gastroenterology
[2] The University of Tokyo,Department of Gastroenterology
[3] Mitsui Memorial Hospital,Department of Gastroenterology
[4] Kanto Central Hospital,Department of Gastroenterology
[5] Japanese Red Cross Hospital,Department of Gastroenterology
[6] JR Tokyo General Hospital,Department of Gastroenterology
[7] Teikyo Chiba Medical Center,undefined
[8] Yamanashi Prefectural Hospital Organization,undefined
来源：
British Journal of Cancer | 2012年 / 106卷
关键词：
chemotherapy; gemcitabine; pancreatic cancer; randomised controlled trial; S-1;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1934 / 1939
页数：5
相关论文
共 50 条
  • [21] PHASE II STUDY OF GEMCITABINE/S-1 COMBINATION THERAPY IN PATIENTS WITH ADVANCED BILIARY TRACT CANCER
    Kanai, Masashi
    Hatano, Etsuro
    Tsumura, Takehiko
    Asada, Masanori
    Matsumoto, Shigemi
    Nishimura, Takafumi
    Hamada, Akihiko
    Inoue, Naoya
    Mori, Yukiko
    Yoshimura, Kenichi
    Tada, Shinsuke
    Yanagihara, Kazuhiro
    Yazumi, Shujiro
    Osaki, Yukio
    Chiba, Tsutomu
    ANNALS OF ONCOLOGY, 2010, 21 : 19 - 19
  • [22] GEMCITABINE AND S-1 COMBINATION THERAPY IN PATIENTS WITH ADVANCED STAGE OF PANCREATIC CANCER
    Ouchi, J.
    Hijioka, M.
    Harada, S.
    Maruyama, Y.
    Funakoshi, A.
    PANCREAS, 2008, 37 (04) : 488 - 488
  • [23] Clinical outcome of gemcitabine/S-1 combination therapy for advanced pancreatic cancer
    Yamauchi, Junichi
    Kanai, Masashi
    Matsumoto, Shigemi
    Nishimura, Takafumi
    Yazumi, Shujiro
    Kami, Kazuhiro
    Kawaguchi, Yoshiya
    Yasuda, Hiroyasu
    Kitano, Toshiyuki
    Misawa, Akiko
    Ishiguro, Hiroshi
    Yoshikawa, Kiyotsugu
    Yanagihara, Kazuhiro
    Fukushima, Masanori
    Doi, Ryuichiro
    Chiba, Tsutomu
    PANCREAS, 2008, 36 (03) : 327 - 328
  • [24] A phase II study of gemcitabine, erlotinib and S-1 in patients with advanced pancreatic cancer
    Han, Boram
    Kim, Bum Jun
    Kim, Hyeong Su
    Choi, Dae Ro
    Shim, Byoung Yong
    Lee, Kyung Hee
    Kim, Jin Won
    Kim, Jung Han
    Song, Hunho
    Kim, Jong Hyeok
    Park, Choong Kee
    Lee, Jung Woo
    Kim, Min-Jeong
    Zang, Dae Young
    JOURNAL OF CANCER, 2021, 12 (03): : 912 - 917
  • [25] Axitinib (AG-013736) and gemcitabine vs gemcitabine in advanced pancreatic cancer: a randomised phase II study
    Spano, J.
    Chodkiewicz, C.
    Maurel, J.
    Wong, R.
    Wasan, H. S.
    Barone, C.
    Liau, K. F.
    Pithavala, Y.
    Bycott, P. W.
    Rixe, O.
    EJC SUPPLEMENTS, 2007, 5 (04): : 261 - 261
  • [26] A phase I study of combination chemotherapy with gemcitabine and oral S-1 for advanced pancreatic cancer
    Ueno, H
    Okusaka, T
    Ikeda, M
    Ishiguro, Y
    Morizane, C
    Matsubara, J
    Furuse, J
    Ishii, H
    Nagase, M
    Nakachi, K
    ONCOLOGY, 2005, 69 (05) : 421 - 427
  • [27] Efficacy of nab-paclitaxel vs. Gemcitabine in combination with S-1 for advanced pancreatic cancer: A multicenter phase II randomized trial
    Guo, Xi
    Lou, Wenhui
    Xu, Yaolin
    Zhuang, Rongyuan
    Yao, Lie
    Wu, Junwei
    Fu, Deliang
    Zhang, Jun
    Liu, Jing
    Rong, Yefei
    Jin, Dayong
    Wu, Wenchuan
    Xu, Xuefeng
    Ji, Yuan
    Wu, Lili
    Lv, Minzhi
    Yao, Xiuzhong
    Liu, Xiaowei
    Wang, Dansong
    Kuang, Tiantao
    Liu, Liang
    Wang, Wenquan
    Liu, Tianshu
    Zhou, Yuhong
    ONCOLOGY LETTERS, 2024, 27 (04)
  • [28] Multicenter Phase II Study of Gemcitabine and S-1 Combination Therapy (GS Therapy) in Patients With Metastatic Pancreatic Cancer
    Ueno, Hideki
    Okusaka, Takuji
    Furuse, Junji
    Yamao, Kenji
    Funakoshi, Akihiro
    Boku, Narikazu
    Ohkawa, Shinichi
    Yokosuka, Osamu
    Tanaka, Katsuaki
    Moriyasu, Fuminori
    Nakamori, Shoji
    Sato, Tosiya
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2011, 41 (08) : 953 - 958
  • [29] A randomized phase II study of gemcitabine plus S-1 versus gemcitabine alone in patients with unresectable pancreatic cancer.
    Omuro, Y.
    Ikari, T.
    Ishii, H.
    Ozaka, M.
    Suyama, M.
    Matsumura, Y.
    Itoi, T.
    Egawa, N.
    Yano, S.
    Hanada, K.
    Kimura, Y.
    Ukita, T.
    Ishida, Y.
    Tani, M.
    Ohoka, S.
    Hirose, Y.
    Hijioka, S.
    Watanabe, R.
    Ikeda, T.
    Nakajima, T.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [30] Retrospective Study of Gemcitabine plus S-1 versus Gemcitabine Alone in Cases with Unresectable Advanced Pancreatic Cancer
    Suzuki, Shuji
    Ozaki, Yuhi
    Saida, Shin
    Kaji, Satoshi
    Koike, Nobusada
    Harada, Nobuhiko
    Hayashi, Tsuneo
    Suzuki, Mamoru
    HEPATO-GASTROENTEROLOGY, 2013, 60 (124) : 916 - 920
12345